Cargando…

QS-21: A Potent Vaccine Adjuvant

Detalles Bibliográficos
Autores principales:	Zhu, Daming, Tuo, Wenbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874334/ https://www.ncbi.nlm.nih.gov/pubmed/27213168 http://dx.doi.org/10.4172/2329-6836.1000e113

Ejemplares similares

An adjuvanted zoster vaccine elicits potent cellular immune responses in mice without QS21
por: Nam, Hyo Jung, et al.
Publicado: (2022)

Potent response of QS-21 as a vaccine adjuvant in the skin when delivered with the Nanopatch, resulted in adjuvant dose sparing
por: Ng, Hwee-Ing, et al.
Publicado: (2016)

Development of a minimal saponin vaccine adjuvant based on QS-21
por: Fernández-Tejada, Alberto, et al.
Publicado: (2014)

Lysosome-Dependent Activation of Human Dendritic Cells by the Vaccine Adjuvant QS-21
por: Welsby, Iain, et al.
Publicado: (2017)

Meta-Analysis on Randomized Controlled Trials of Vaccines with QS-21 or ISCOMATRIX Adjuvant: Safety and Tolerability
por: Bigaeva, Emilia, et al.
Publicado: (2016)

QS-21 enhances the early antibody response to oil adjuvant foot-and-mouth disease vaccine in cattle
por: Çokçalışkan, Can, et al.
Publicado: (2016)

Development of Improved Vaccine Adjuvants Based on the Saponin Natural Product QS-21 through Chemical Synthesis
por: Fernández-Tejada, Alberto, et al.
Publicado: (2016)

Liposome and QS-21 Combined Adjuvant Induces theHumoral and Cellular Responses of Acellular Pertussis Vaccine in a Mice Model
por: Yang, Baifeng, et al.
Publicado: (2023)

Abstract QS21: Leadership In Plastic Surgery
por: Murphy, Carolyn P., et al.
Publicado: (2019)

A Comparison of Intramuscular and Subcutaneous Administration of LigA Subunit Vaccine Adjuvanted with Neutral Liposomal Formulation Containing Monophosphoryl Lipid A and QS21
por: Techawiwattanaboon, Teerasit, et al.
Publicado: (2020)

Atomic Model and Micelle Dynamics of QS-21 Saponin
por: Pedebos, Conrado, et al.
Publicado: (2014)

1238. The Novel Semisynthetic Saponin Adjuvant TQL1055 Enhances the Antibody Response to Pertussis Vaccine with an Improved Tolerability Profile over QS-21
por: Buzz, Chloe, et al.
Publicado: (2020)

Test Of Closure Of Orbit BumPS In Qs3, Qs4, Qs5, Qs6
por: Koutchouk, Jean-Pierre, et al.
Publicado: (1991)

Anmerkung zu LG Nürnberg-Fürth, Beschl. v. 24.1.2022 – 18 Qs 24/21, 18 Qs 25/21
por: Gierok, Markus, et al.
Publicado: (2022)

Ionizable Lipid Nanoparticles Enhanced the Synergistic Adjuvant Effect of CpG ODNs and QS21 in a Varicella Zoster Virus Glycoprotein E Subunit Vaccine
por: Luan, Ning, et al.
Publicado: (2022)

Similarities and differences of chemical compositions and physical and functional properties of adjuvant system 01 and army liposome formulation with QS21
por: Alving, Carl R., et al.
Publicado: (2023)

Replacing the Rhamnose‐Xylose Moiety of QS‐21 with Simpler Terminal Disaccharide Units Attenuates Adjuvant Activity in Truncated Saponin Variants
por: Fuentes, Roberto, et al.
Publicado: (2021)

QS21-Initiated Fusion of Liposomal Small Unilamellar Vesicles to Form ALFQ Results in Concentration of Most of the Monophosphoryl Lipid A, QS21, and Cholesterol in Giant Unilamellar Vesicles
por: Abucayon, Erwin G., et al.
Publicado: (2023)

Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer’s Disease
por: Hüll, Michael, et al.
Publicado: (2017)

Specificity analysis of sera from breast cancer patients vaccinated with MUC1-KLH plus QS-21
por: Adluri, S, et al.
Publicado: (1999)

Updated insights into the mechanism of action and clinical profile of the immunoadjuvant QS-21: A review()
por: Lacaille-Dubois, Marie-Aleth
Publicado: (2019)

A Liquid Chromatography High-Resolution Tandem Mass Spectrometry Method to Quantify QS-21 Adjuvant and Its Degradation Products in Liposomal Drug Formulations
por: Abucayon, Erwin G., et al.
Publicado: (2023)

Abstract QS21: Exome Mutations In Sun-exposed Skin And Basal Cell Carcinoma
por: Collawn, Sherry S., et al.
Publicado: (2020)

Enhanced Immunogenicity and Protective Efficacy of a Campylobacter jejuni Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21
por: Ramakrishnan, Amritha, et al.
Publicado: (2019)

In-silico analysis of potent Mosquirix vaccine adjuvant leads
por: Onyango, Okello Harrison, et al.
Publicado: (2023)

A potent novel vaccine adjuvant based on straight polyacrylate
por: Garinot, Marie, et al.
Publicado: (2020)

IFNβ Is a Potent Adjuvant for Cancer Vaccination Strategies
por: Audsley, Katherine M., et al.
Publicado: (2021)

QS version 3.0
por: Chang, Yih-Long
Publicado: (1995)

Central Role of CD169(+) Lymph Node Resident Macrophages in the Adjuvanticity of the QS-21 Component of AS01
por: Detienne, Sophie, et al.
Publicado: (2016)

Abstract QS42: Neo - Adjuvant Chemotherapy is Not Associated With Increased Risk of Complications in Immediate Autologous Breast Reconstruction
por: Karamanos, Efstathios, et al.
Publicado: (2018)

Longitudinal displacements of the QS0's and their compensation
por: Roy, G, et al.
Publicado: (1995)

Multifunctional Protein Conjugates with Built-in Adjuvant (Adjuvant-Protein-Antigen) as Cancer Vaccines Boost Potent Immune Responses
por: Du, Jing-Jing, et al.
Publicado: (2020)

In vitro evaluation and molecular docking of QS-21 and quillaic acid from Quillaja saponaria Molina as gastric cancer agents
por: Guzmán, Leda, et al.
Publicado: (2020)

The Ps and Qs of alarmone synthesis in Staphylococcus aureus
por: Yang, Ning, et al.
Publicado: (2019)

A Perspective on the Roles of Adjuvants in Developing Highly Potent COVID-19 Vaccines
por: Zhang, Naru, et al.
Publicado: (2022)

Manganese salts function as potent adjuvants
por: Zhang, Rui, et al.
Publicado: (2021)

A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity
por: Das, Krishna, et al.
Publicado: (2021)

Erratum for Ramakrishnan et al., “Enhanced Immunogenicity and Protective Efficacy of a Campylobacter jejuni Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21”
por: Ramakrishnan, Amritha, et al.
Publicado: (2019)

Correction for Ramakrishnan et al., “Enhanced Immunogenicity and Protective Efficacy of a Campylobacter jejuni Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21”
por: Ramakrishnan, Amritha, et al.
Publicado: (2019)

Anmerkung zu LG Osnabrück, Beschl. v. 26.10.2021 – 3 Qs 38/21 (AG Osnabrück)
por: Lorenz, Henning, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2jkdt37pigia96lejuip8a1hsr